Human CASR mutations are known to be causative for primary hyperparathyroidism (HP) (Bilezikian et al. 2005) and familial benign hypocalciuric hypercalcemia (FHH) (Pollak et al. 1994). Here, CASR is linked to primary hyperparathyroidism.